Clinical Trial Update: Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating brivaracetam as an add-on treatment for Unverricht-Lundborg disease in adolescents and adults has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Unverricht-lundborg Disease

Drugs mentioned

• BRIVARACETAM (brivaracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Unverricht-Lundborg Disease | Phase 3 | Status: COMPLETED | Results posted: 2016-04-13